PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|July 2, 2014
- Pharmaceutical Technology-07-02-2014
- Volume 38
- Issue 7
Powderization System Improves Productivity
Author(s)Melanie Sena
Powderization System Improves Productivity
Shimadzu Scientific Instruments’ Crude2Pure (C2P) i s an automated purification/powderization technology that eliminates time-consuming operations and allows researchers to focus on synthesizing and isolating target compounds. C2P is designed for use with preparative liquid chromatography. The system uses trap concentration to purify target compounds from synthetic products consisting of low molecular weight organic compounds and complicated natural substances, and recovers them as highly pure powders. The C2P uses the Shim-pack C2P-H trapping column to retain target compounds and remove only residual components by rinse washing to purify the sample. In addition, the C2P accelerates the sample concentration and powderization process by directly eluting the target compounds retained in the trapping column through a spray nebulizer.
Articles in this issue
over 12 years ago
Trends in Manufacturing and Equipmentover 12 years ago
The Mainstreaming of Continuous Flow API Synthesisover 12 years ago
Health Systems Raise the Bar on Reimbursing New Drugsover 12 years ago
Data Integrityover 12 years ago
Environmental Monitoring System Improves Efficiencyover 12 years ago
Automating Online Sampling of Bioprocessesover 12 years ago
Sieve Shakers Ensure Reliabilityover 12 years ago
Laboratory Filter-Dryer Enables ScalabilityRelated to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.